Search
Carbinoxamine H1-Antihistamine Action
smpdb.ca/view/SMP0058797Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaDiphenylpyraline H1-Antihistamine Action
smpdb.ca/view/SMP0058908Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaChlorcyclizine H1-Antihistamine Action
smpdb.ca/view/SMP0058931Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaPhenbenzamine H1-Antihistamine Action
smpdb.ca/view/SMP0059702Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaHydroxyethylpromethazine H1-Antihistamine Action
smpdb.ca/view/SMP0059710Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaOxomemazine H1-Antihistamine Action
smpdb.ca/view/SMP0059738Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAcrivastine H1-Antihistamine Action
smpdb.ca/view/SMP0059881Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaThiazinamium H1-Antihistamine Action
smpdb.ca/view/SMP0060742Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaQuifenadine H1-Antihistamine Action
smpdb.ca/view/SMP0060743Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaMebhydrolin H1-Antihistamine Action
smpdb.ca/view/SMP0061052Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alpha